4th Quarter - Report

CAPITOL COUNSEL LLC for BLANDFORD BIOTECH

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 15, 2023 $50,000 Replaced
4th Quarter - Termination Apr 18, 2023 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Advocacy for emergency use authorization of SARS-CoV-2 Rapid Antigen Detection Test and assistance in obtaining government contracts.

LobbyistCovered position, as disclosed
JEFFREY CARROLL —
JOHN JONAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Government Issues GOV

Advocacy for emergency use authorization of SARS-CoV-2 Rapid Antigen Detection Test and assistance in obtaining government contracts.

LobbyistCovered position, as disclosed
JEFFREY CARROLL —
JOHN JONAS —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.